PVI
BCAB icon

Pura Vida Investments’s BioAtla BCAB Stock Holding History

Pura Vida Investments’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-180
Closed -$457K – 226
2021
Q1 		$457K Sell
180
-1,346
-88% -$3.45M 0.01% 203
2020
Q4 		$2.6M Buy
+1,526
New +$2.55M 0.09% 134

Other funds holding BCAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Pura Vida Investments's BCAB Position: Q2 2021 in Review

Pura Vida Investments sold out of BioAtla (BCAB) in Q2 2021, closing a stake of 180 shares — an estimated $457K sold.

Pura Vida Investments first reported a position in BCAB in Q4 2020 and held it in 2 quarters. The position peaked at $2.6M in Q4 2020. 76 funds tracked by Wall St. Rank hold BCAB as of Q2 2021.

  • Pura Vida Investments reported no remaining BioAtla position as of Q2 2021 after selling out during the quarter.
  • Pura Vida Investments sold 180 BioAtla shares in Q2 2021, an estimated $457K.
  • Pura Vida Investments first reported a position in BioAtla in Q4 2020 and held it in 2 quarters.
  • Pura Vida Investments's BioAtla position peaked at $2.6M in Q4 2020.
  • 76 funds tracked by Wall St. Rank held BioAtla as of Q2 2021.

Based on Pura Vida Investments's 13F filing for Q2 2021, filed 16 Aug 2021.